Clinical trial
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck…
NCT00002951 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00002951 |
|---|---|
| Title | Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer |
| Official title | Hyperfractionated Radiotherapy With Concomitant Fluorouracil and Hydroxurea for Intermediate Stage Cancer of the Head and Neck |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Head and Neck Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | fluorouracil, hydroxyurea, surgical procedure, radiation therapy |
| Enrollment | 53 |
| Start date | Jun 1, 1996 |
| Primary completion | Jun 1, 2004 |
| Completion | Jul 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: